<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>INTRODUCTION: Small Bowel <z:mp ids='MP_0001794'>Bacterial</z:mp> <z:hpo ids='HP_0001548'>Overgrowth</z:hpo> (SBBO) has recently been proposed to be prevalent in patients with <z:e sem="disease" ids="C1262211" disease_type="Disease or Syndrome" abbrv="">diarrhoea predominant Irritable Bowel Syndrome</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IBS</z:e>-D) </plain></SENT>
<SENT sid="1" pm="."><plain>However prevalence figures in studies have varied widely dependant on the diagnostic test used, with low prevalence rates of 4% using jejunal aspirate and culture, to between 38-84% using hydrogen breath tests </plain></SENT>
<SENT sid="2" pm="."><plain>This study used the <z:chebi fb="105" ids="17234">Glucose</z:chebi> Hydrogen and <z:chebi fb="158" ids="16183">Methane</z:chebi> Breath Test (GHBT) to determine if there was a relationship between patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IBS</z:e>-D symptoms and SBBO </plain></SENT>
<SENT sid="3" pm="."><plain>Concurrently any clinical features or baseline laboratory investigations indicative of a high likelihood of SBBO was investigated </plain></SENT>
<SENT sid="4" pm="."><plain>METHODS: A retrospective analysis of patient hospital records for patients referred to a tertiary GI <z:mp ids='MP_0001532'>Physiology</z:mp> Department at Sheffield Teaching Hospitals (STH) between January 1988-2013 for a routine GHBT was conducted </plain></SENT>
<SENT sid="5" pm="."><plain>Data was split into two groups </plain></SENT>
<SENT sid="6" pm="."><plain>Group 1 included <z:hpo ids='HP_0000001'>all</z:hpo> patients demographics referred for a GHBT (1998-2010) to investigate characteristics predictive of SBBO </plain></SENT>
<SENT sid="7" pm="."><plain>Group 2 included patients who fulfilled ROME III criteria for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IBS</z:e>-D who underwent a GHBT (2010-2012) </plain></SENT>
<SENT sid="8" pm="."><plain>A positive result for SBBO was defined as a rise in hydrogen or <z:chebi fb="158" ids="16183">methane</z:chebi> levels of ≥10 ppm over baseline levels </plain></SENT>
<SENT sid="9" pm="."><plain>RESULTS: In group 1 786 patients were identified (276 male, mean age 54) </plain></SENT>
<SENT sid="10" pm="."><plain>Overall 175/786 (22.3%) tests were positive </plain></SENT>
<SENT sid="11" pm="."><plain>Laboratory investigations and patient characteristics predictive of a positive result were low <z:chebi fb="9" ids="17439">vitamin B12</z:chebi> (p &lt; 0.001), low albumin &lt;30g/dL (p &lt; 0.001), concurrent use of a <z:chebi fb="0" ids="49200">proton pump inhibitor</z:chebi> (<z:chebi fb="4" ids="53266">PPI</z:chebi>) (p = 0.002), previous Bilroth II gastroenterostomy (p &lt; 0.001), previous vagotomy (p &lt; 0.001), right hemi-colectomy (p = 0.003), <z:e sem="disease" ids="C0007570" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">coeliac disease</z:e> (p &lt; 0.001), and small bowel <z:hpo ids='HP_0100280'>Crohn's disease</z:hpo> (p = 0.04) and age over 65 years (p &lt; 0.001) </plain></SENT>
<SENT sid="12" pm="."><plain>Symptoms predictive of a positive GHBT included diarrhoea (p = 0.03) and <z:hpo ids='HP_0001824'>weight loss</z:hpo> (p &lt; 0.01) </plain></SENT>
<SENT sid="13" pm="."><plain>In group 2 135/834 patients fulfilled ROME III criteria for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IBS</z:e>-D (42 male, mean age 43 years) </plain></SENT>
<SENT sid="14" pm="."><plain>Overall 26/135 (19.3%) tests were positive </plain></SENT>
<SENT sid="15" pm="."><plain>A significant correlation was found between patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IBS</z:e>-D symptoms and SBBO (p = 0.01) </plain></SENT>
<SENT sid="16" pm="."><plain>Characteristics predictive of SBBO in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IBS</z:e>-D patients were previous small bowel surgery (p = 0.04) and <z:e sem="disease" ids="C0494805,C0005750" disease_type="Disease or Syndrome" abbrv="">blind loop syndrome</z:e> (p = 0.04) </plain></SENT>
<SENT sid="17" pm="."><plain>CONCLUSION: This study has further highlighted the proposed relationship of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IBS</z:e>-D symptoms and an increased prevalence of SBBO </plain></SENT>
<SENT sid="18" pm="."><plain>In <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IBS</z:e>-D patients factors predictive of SBBO were previous small bowel surgery and <z:e sem="disease" ids="C0494805,C0005750" disease_type="Disease or Syndrome" abbrv="">blind loop syndrome</z:e> </plain></SENT>
<SENT sid="19" pm="."><plain>For the sub-cohort of patients attending for a GHBT factors predictive of SBBO were patient age (≥65 years), diarrhoea, <z:hpo ids='HP_0001824'>weight loss</z:hpo>, use of a <z:chebi fb="4" ids="53266">PPI</z:chebi>, previous Bilroth II gastroenterostomy, previous vagotomy, right hemi-colectomy, <z:e sem="disease" ids="C0007570" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">coeliac disease</z:e>, small bowel <z:hpo ids='HP_0100280'>Crohn's disease</z:hpo>, low <z:chebi fb="9" ids="17439">Vitamin B12</z:chebi> and low albumin </plain></SENT>
<SENT sid="20" pm="."><plain>DISCLOSURE OF INTEREST: None Declared </plain></SENT>
</text></document>